The main objective of this research project is to create the first full-thickness cornea-on-chip, which comprises a 3D construct with every cellular layer of the cornea. This construct is embedded in a microfluidic chip with two channels that are continuously perfused. The epithelial side of the

Last updated on: 27-07-2022 - 09:35

Contact: Joris Van Meenen
Organisation: University of Antwerp (UAntwerpen)
Status: Still in development
We developed a high-throughput live-cell imaging-based organoid analysis platform, Organoid Brightfield Identification-based Therapy Screening (Orbits), that allows for kinetic monitoring of organoid growth and drug responses in routine extracellular matrix domes, high-throughput 384-well

Last updated on: 16-03-2022 - 13:59

Contact: Christophe Deben
Organisation: University of Antwerp (UAntwerpen)
Status: Internally validated
Cardiomyocytes derived from induced pluripotent stem cells (iPSC-CMs) offer an attractive platform for cardiovascular research, including disease modeling, drug toxicity testing and development of regenerative therapies. Patient-specific iPSC-CMs are very useful to study disease pathogenesis and

Last updated on: 30-06-2020 - 14:13

Contact: Maaike Alaerts
Organisation: University of Antwerp (UAntwerpen)
Status: Still in development, Internally validated
Vascular smooth muscle cell (VSMC) deficiency plays a pivotal role in aneurysm development. Unfortunately, access to native VSMCs of patients and (particularly) control individuals is extremely limited. It has been shown that iPSC-derived VSMCs recapitulate the yet known disease processes very well.

Last updated on: 03-06-2020 - 13:51

Organisation: University of Antwerp (UAntwerpen)
Status: Still in development, Internally validated
The GIDM-colon is a validated in vitro model that allows the study of the availability of compounds and the metabolisation at the level of the colon. The human physiological conditions of the gastrointestinal tract (stomach, small intestine and colon) are mimicked. The continiuous flow eliminates

Last updated on: 03-02-2020 - 08:44

Organisation: University of Antwerp (UAntwerpen)
Status: History of use, Internally validated, Published in peer reviewed journal
A compound of interest (e.g. new psychoactive substance, endocrine disrupting compound, ...) is incubated with human liver microsomes and liver cytosolic fractions to generate both Phase I and II metabolites. Samples are prepared for analysis using a simple method in order to avoid possible losses

Last updated on: 08-11-2019 - 14:01

Organisation: University of Antwerp (UAntwerpen)
Status: Published in peer reviewed journal